07:00 , May 23, 2013 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Fibroblast activation protein (FAP) In vitro studies identified a boronic acid-based inhibitor of FAP that could...
08:00 , Jan 31, 2008 |  BC Innovations  |  Cover Story

CD200: A Solid Argument

The two companies developing anti-CD200 antibodies to treat blood cancers-Alexion Pharmaceuticals Inc. and Trillium Therapeutics Inc.-might have had a new indication land in their laps. In a paper published in The Journal of Clinical Investigation,1...